CTXR - Citius Pharmaceuticals, Inc.
0.8351
-0.114 -13.591%
Share volume: 937,385
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.95
-0.11
-0.12%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-14-2024 | 08-12-2024 | 02-14-2025 | 02-14-2025 | 05-14-2025 | 08-12-2025 | 12-23-2025 | 02-13-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 3.944 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 789.208 K | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 3.155 M | |
| nan% | nan% | nan% | nan% | nan% | |||||
| Operating expenses | 7.892 M | 7.572 M | 8.409 M | 7.515 M | 8.559 M | 6.068 M | 5.548 M | 7.894 M | |
| Selling general and admin | 4.286 M | 4.809 M | 5.494 M | 5.388 M | 4.792 M | 4.447 M | 3.906 M | 5.721 M | |
| Research and development | 3.606 M | 2.764 M | 2.915 M | 2.127 M | 3.767 M | 1.621 M | 1.642 M | 2.173 M | |
| Total expenses | 10.970 M | 10.634 M | 11.050 M | 10.040 M | 11.261 M | 8.788 M | 8.437 M | 12.174 M | |
| -3.06% | 3.91% | -9.15% | 12.16% | -21.96% | -3.99% | 44.29% | |||
| Operating income | -10.970 M | -10.634 M | -11.050 M | -10.040 M | -11.261 M | -8.788 M | -8.437 M | -9.019 M | |
| Ebit | -10.970 M | -10.634 M | -11.050 M | -10.040 M | -11.261 M | -8.788 M | -8.437 M | -9.019 M | |
| Pretax income | -8.400 M | -10.429 M | -10.933 M | -10.017 M | -11.247 M | -8.940 M | -8.479 M | -9.130 M | |
| 24.16% | 4.83% | -8.38% | 12.28% | -20.52% | -5.15% | 7.67% | |||
| Income tax | 144.000 K | 144.000 K | 144.000 K | 264.240 K | 264.240 K | 264.240 K | 264.240 K | 264.240 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -8.544 M | -10.573 M | -11.077 M | -10.281 M | -11.512 M | -9.204 M | -8.744 M | -9.394 M | |
| -23.75% | -4.77% | 7.19% | -11.97% | 20.05% | 5.00% | -7.44% |